Skip to main content
Erschienen in: memo - Magazine of European Medical Oncology 1/2013

01.02.2013 | editorial

Future of stereotactic intervention in lung cancer

verfasst von: Prof. Karin S. Kapp, MD

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

With the recent advances in technology, highly sophisticated hardware (linear accelerators specially designed for Stereotactic Radio-Surgery or Stereotactic Body Radiation Therapy (SBRT) using novel image guidance prior to and during the procedure) and equally sophisticated planning treatment software (static and dynamic Intensity Modulated Radiation Therapy) became available, allowing for ablative doses to be delivered with an accuracy of less than 1 mm to targets which are non-static due to respiratory motion.
Literatur
1.
Zurück zum Zitat Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy of primary lung cancer and pulmonary metastases: a non-invasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys. 2004;60(1):186–96.PubMedCrossRef Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy of primary lung cancer and pulmonary metastases: a non-invasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys. 2004;60(1):186–96.PubMedCrossRef
2.
Zurück zum Zitat Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Skamoto T, Sakamoto M, Mitsumori M, Shibuya K, Araki N, Yano S, Hiraoka M. Clinical outcomes of a phase I/II of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2005;63(5):1427–31.PubMedCrossRef Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Skamoto T, Sakamoto M, Mitsumori M, Shibuya K, Araki N, Yano S, Hiraoka M. Clinical outcomes of a phase I/II of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2005;63(5):1427–31.PubMedCrossRef
3.
Zurück zum Zitat Timmermann R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, Fowler J, Gore E, Choy H. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303(11):1070–6.CrossRef Timmermann R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, Fowler J, Gore E, Choy H. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303(11):1070–6.CrossRef
4.
Zurück zum Zitat Nagata Y, Wulf J, Lax I, Timmermann R, Zimmermann F, Stojkovski I, Jeremic B. Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the international atomic energy agency. Int J Radiat Oncol Biol Phys. 2011;79:660–9.PubMedCrossRef Nagata Y, Wulf J, Lax I, Timmermann R, Zimmermann F, Stojkovski I, Jeremic B. Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the international atomic energy agency. Int J Radiat Oncol Biol Phys. 2011;79:660–9.PubMedCrossRef
5.
Zurück zum Zitat Martin A, Gaya A. Stereotactic body radiotherapy: a review. Clin Oncol. 2010;22:157–72.CrossRef Martin A, Gaya A. Stereotactic body radiotherapy: a review. Clin Oncol. 2010;22:157–72.CrossRef
6.
Zurück zum Zitat ACOSOG Z4099/RTOG1021. Randomized phase III study of sublobar resection (+/− brachytherapy) versus stereotactic body radiation therapy in high risk patients with stage I non-small cell lung cancer (NSCLC). 2011. http://www.acosog.org. Accessed 28 Nov 2012. ACOSOG Z4099/RTOG1021. Randomized phase III study of sublobar resection (+/− brachytherapy) versus stereotactic body radiation therapy in high risk patients with stage I non-small cell lung cancer (NSCLC). 2011. http://​www.​acosog.​org.​ Accessed 28 Nov 2012.
7.
Zurück zum Zitat Timmerman RD. Surgery versus stereotactic body radiation therapy for early-stage lung cancer: who’s down for the count? J Clin Oncol. 2010;28(6):907–9.PubMedCrossRef Timmerman RD. Surgery versus stereotactic body radiation therapy for early-stage lung cancer: who’s down for the count? J Clin Oncol. 2010;28(6):907–9.PubMedCrossRef
Metadaten
Titel
Future of stereotactic intervention in lung cancer
verfasst von
Prof. Karin S. Kapp, MD
Publikationsdatum
01.02.2013
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 1/2013
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-012-0066-4

Weitere Artikel der Ausgabe 1/2013

memo - Magazine of European Medical Oncology 1/2013 Zur Ausgabe